Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Book of Toxins comprises 11 original contributions and one review. New findings regarding presence of mycotoxins in aromatic and medicinal plants, mango and orange juice, juices, pulps, jams, and beer, from Morocco, Pakistan, and Portugal are reported. In these studies, innovative techniques to study their presence has been developed, including liquid chromatography coupled with time-of-flight mass spectrometry to analyse mycotoxins and conjugated mycotoxins. Novel strategies to detect mycotoxin presence and comparisons the characteristics of a rapid quantitative analysis of different mycotoxins (deoxynivalenol, ochratoxin A, patulin, sterigmatocystin, and zearalenone) are also presented using acetyl- and butyrylcholinesterases and photobacterial strains of luminescent cells. Additionally, toxicological effects of zearalenone metabolites and beauvericin on SH-SY5Y neuronal cells are presented. One important point in the control of mycotoxins is related to decontaminated strategies, and in this sense the efficacy of potentially probiotic fruit-derived Lactobacillus isolates in removing aflatoxin M1 (AFM1) is presented. Other mycotoxin decontaminated techniques included in this book are electron beam irradiation (EBI) and degradation of zearalenone and ochratoxin A using ozone. Finally, a review that summarizes the newly discovered macrocyclic trichothecenes and their bioactivities over the last decade is included.The evaluation of the presence of mycotoxins in different matrices is achieved through different analytical tools (including quantitative or qualitative determinations). Studies of mycotoxin isolation, using chromatographyc equipment coupled to spectrometry detectors (QTrap-MS/MS, MS/MS tandem, QTOF-MS/MS), are the most useful tools to control their presence. All these studies represent key steps in the establishment of the limits of detection, limits of quantification, points of identification, accuracy, reproducibility, and repeatability of different procedures. The maximum permitted or recommended levels for mycotoxins in different matrices are within a wide range (including the levels tolerated by infants and animals). In addition, decontaminated strategies, as well as control and evaluation of exposure, are demanded by authorities and food safety systems.

patulin --- mango --- orange --- fruit-derived products --- food safety --- regulatory limits --- chitosan --- mycotoxins --- detoxification --- LC-MS/MS --- optimization --- Destruxins --- Bombyx mori --- BmArgRS --- BmLamin-C --- RNA helicase --- binding protein --- ozone --- electron beam irradiation --- degradation --- zearalenone --- ochratoxin A --- SH-SY5Y cells --- zearalenone derivates --- beauvericin --- MTT --- qTOF–MS/MS --- beer --- immunoaffinity clean-up --- LC-FD --- human risk assessment --- Enniatin B1 --- biomonitoring --- in vivo --- metabolomics --- high resolution mass spectrometry (HRMS) --- macrocyclic trichothecenes --- bioactivities --- putative biosynthetic pathway --- macrocycle formation --- entomopathogens --- mycoinsecticides --- secondary metabolites --- insect pathogenesis --- acetamiprid accumulation --- aflatoxin M1 --- Lactobacillus --- probiotics --- binding --- bioluminescent bacteria --- immobilized cells --- cholinesterase-based analysis --- analytical characteristics --- enzymatic detoxification --- co-occurrence --- Q-TOF-LC/MS --- exposure --- Morocco --- n/a --- qTOF-MS/MS

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Phenolic compounds are an extremely diverse class of ubiquitous secondary metabolites produced by a variety of organisms playing different biological roles. They have numerous types of demonstrated bioactivities, including antioxidant, antimicrobial, anti-inflammatory, antitumoral, immunomodulator, neuroprotective, cardioprotective, and antidiabetic activities. Marine organisms produce a vast collection of unique phenolic structures, some of them not found in terrestrial habitats. Progress in different aspects is rapidly advancing, and this Special Issue will provide updated information and recent studies on marine phenolics. Specially, this issue is focused on their chemical characterization, elucidation of their structures, evaluation of their biological properties and mechanisms of action, efficient extraction and purification technologies, development of value-added applications, as well as formulation of novel products.

ultrasound assisted extraction --- conventional extraction --- polyphenols --- phlorotannin --- macroalgae --- antioxidant capacity --- seaweeds --- antioxidant potential --- LC-ESI-QTOF-MS/MS --- HPLC-PDA --- seaweed polyphenols --- hypoglycemic effect --- starch digestion --- enzyme inhibition --- cochayuyo --- seaweed polyphenolics --- polyphenolics extractions --- phlorotannins --- bromophenols --- flavonoids --- phenolic terpenoids --- polyphenolics bioactivities --- marine phenolics --- emerging technologies --- extraction --- Ascophyllum --- seaweed --- health benefits --- isomers --- LC-MSn --- diversity --- phenolics --- simple phenolics --- seawater --- algae --- seagrass --- biological activity --- brown seaweeds --- microwave-assisted extraction --- response surface methodology --- antioxidant --- antiradical activity --- xanthine oxidase --- α-glucosidase

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Book of Toxins comprises 11 original contributions and one review. New findings regarding presence of mycotoxins in aromatic and medicinal plants, mango and orange juice, juices, pulps, jams, and beer, from Morocco, Pakistan, and Portugal are reported. In these studies, innovative techniques to study their presence has been developed, including liquid chromatography coupled with time-of-flight mass spectrometry to analyse mycotoxins and conjugated mycotoxins. Novel strategies to detect mycotoxin presence and comparisons the characteristics of a rapid quantitative analysis of different mycotoxins (deoxynivalenol, ochratoxin A, patulin, sterigmatocystin, and zearalenone) are also presented using acetyl- and butyrylcholinesterases and photobacterial strains of luminescent cells. Additionally, toxicological effects of zearalenone metabolites and beauvericin on SH-SY5Y neuronal cells are presented. One important point in the control of mycotoxins is related to decontaminated strategies, and in this sense the efficacy of potentially probiotic fruit-derived Lactobacillus isolates in removing aflatoxin M1 (AFM1) is presented. Other mycotoxin decontaminated techniques included in this book are electron beam irradiation (EBI) and degradation of zearalenone and ochratoxin A using ozone. Finally, a review that summarizes the newly discovered macrocyclic trichothecenes and their bioactivities over the last decade is included.The evaluation of the presence of mycotoxins in different matrices is achieved through different analytical tools (including quantitative or qualitative determinations). Studies of mycotoxin isolation, using chromatographyc equipment coupled to spectrometry detectors (QTrap-MS/MS, MS/MS tandem, QTOF-MS/MS), are the most useful tools to control their presence. All these studies represent key steps in the establishment of the limits of detection, limits of quantification, points of identification, accuracy, reproducibility, and repeatability of different procedures. The maximum permitted or recommended levels for mycotoxins in different matrices are within a wide range (including the levels tolerated by infants and animals). In addition, decontaminated strategies, as well as control and evaluation of exposure, are demanded by authorities and food safety systems.

Medicine --- patulin --- mango --- orange --- fruit-derived products --- food safety --- regulatory limits --- chitosan --- mycotoxins --- detoxification --- LC-MS/MS --- optimization --- Destruxins --- Bombyx mori --- BmArgRS --- BmLamin-C --- RNA helicase --- binding protein --- ozone --- electron beam irradiation --- degradation --- zearalenone --- ochratoxin A --- SH-SY5Y cells --- zearalenone derivates --- beauvericin --- MTT --- qTOF-MS/MS --- beer --- immunoaffinity clean-up --- LC-FD --- human risk assessment --- Enniatin B1 --- biomonitoring --- in vivo --- metabolomics --- high resolution mass spectrometry (HRMS) --- macrocyclic trichothecenes --- bioactivities --- putative biosynthetic pathway --- macrocycle formation --- entomopathogens --- mycoinsecticides --- secondary metabolites --- insect pathogenesis --- acetamiprid accumulation --- aflatoxin M1 --- Lactobacillus --- probiotics --- binding --- bioluminescent bacteria --- immobilized cells --- cholinesterase-based analysis --- analytical characteristics --- enzymatic detoxification --- co-occurrence --- Q-TOF-LC/MS --- exposure --- Morocco --- patulin --- mango --- orange --- fruit-derived products --- food safety --- regulatory limits --- chitosan --- mycotoxins --- detoxification --- LC-MS/MS --- optimization --- Destruxins --- Bombyx mori --- BmArgRS --- BmLamin-C --- RNA helicase --- binding protein --- ozone --- electron beam irradiation --- degradation --- zearalenone --- ochratoxin A --- SH-SY5Y cells --- zearalenone derivates --- beauvericin --- MTT --- qTOF-MS/MS --- beer --- immunoaffinity clean-up --- LC-FD --- human risk assessment --- Enniatin B1 --- biomonitoring --- in vivo --- metabolomics --- high resolution mass spectrometry (HRMS) --- macrocyclic trichothecenes --- bioactivities --- putative biosynthetic pathway --- macrocycle formation --- entomopathogens --- mycoinsecticides --- secondary metabolites --- insect pathogenesis --- acetamiprid accumulation --- aflatoxin M1 --- Lactobacillus --- probiotics --- binding --- bioluminescent bacteria --- immobilized cells --- cholinesterase-based analysis --- analytical characteristics --- enzymatic detoxification --- co-occurrence --- Q-TOF-LC/MS --- exposure --- Morocco

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Drug metabolism/pharmacokinetics and drug interaction studies have been extensively carried out in order to secure the druggability and safety of new chemical entities throughout the development of new drugs. Recently, drug metabolism and transport by phase II drug metabolizing enzymes and drug transporters, respectively, as well as phase I drug metabolizing enzymes, have been studied. A combination of biochemical advances in the function and regulation of drug metabolizing enzymes and automated analytical technologies are revolutionizing drug metabolism research. There are also potential drug–drug interactions with co-administered drugs due to inhibition and/or induction of drug metabolic enzymes and drug transporters. In addition, drug interaction studies have been actively performed to develop substrate cocktails that do not interfere with each other and a simultaneous analytical method of substrate drugs and their metabolites using a tandem mass spectrometer. This Special Issue has the aim of highlighting current progress in drug metabolism/pharmacokinetics, drug interactions, and bioanalysis.

human liver microsomes --- alcohol addiction --- UGT --- ultra-high-pressure liquid chromatography --- adalimumab --- procainamide --- LC-MS/MS --- DA-9805 --- paeonol --- LC-QTOF-MS/MS --- YRA-1909 --- chlorogenic acid --- immunoprecipitation --- Eurycoma longifolia --- CYP --- caffeic acid --- rat --- pharmaceutical excipient --- Korean red ginseng extract --- Stauntonia hexaphylla leaf extract --- bioanalysis --- HPLC-MS/MS --- B6 --- eurycomanone --- bioavailability --- drying technology --- GB3 --- diclofenac --- 129-Glatm1Kul/J --- aglycone --- caffeic acid O-glucuronides --- organic anion transporting polypeptide --- protein precipitation --- metabolic stability --- Fabry disease --- biopharmaceuticals --- imperatorin --- neochlorogenic acid --- gastric ulcer --- saikosaponin a --- hair --- anthraquinone --- acetyl tributyl citrate --- pharmacokinetics --- brain distribution --- mematine --- ethyl glucuronide --- pharmacokinetic --- loxoprofen --- liquid chromatography-quadrupole TOF MS --- glucuronidation --- esomeprazole --- metformin --- cytochrome P450 --- glycoside --- AUDIT score --- protein stability --- efficacy --- LC-HR/MS --- cryptochlorogenic acid --- aceclofenac --- drug interaction --- liquid chromatography-tandem mass spectrometry --- Osthenol --- plasma --- N-acetylprocainamide --- diabetes --- Drugs --- Metabolism. --- Drug metabolism --- Pharmacokinetics

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Dear colleagues, This Special Issue aims to publish new and innovative research that could demonstrate the therapeutic potential of natural health products, through relevant in vitro and/or in vivo biological activities, to prevent or alleviate degenerative diseases. The interaction of natural health products with human microbiota represents an essential aspect, because it could modulate the microbial pattern and alleviate more of a chronic disease’s effects in the case of type 2 diabetes, cardiovascular dysfunctions, neurodegenerative diseases, and inflammatory colon pathologies. Additionally, you are invited to send research based on the effect of different extracts or functional foods used in degenerative pathologies and interactions with human microbiota. We aim to identify new data on in vitro/in vivo research that could demonstrate the bioavailability of natural compounds and the relationship with antioxidant/antimicrobial capacity. Modulated microbiota aspects are expected to be published based on the interaction with natural compounds, natural sweeteners, or other molecules that influence the colon health status.

Technology: general issues --- Biotechnology --- in vitro callus --- cell suspension and root cultures --- biologically active substances --- ecdysteroids --- HPLC --- 1H NMR spectra --- Rhaponticum carthamoides --- Chaga --- medicinal fungi --- biomass yield --- mathematical modeling --- response surface methodology --- bioreactor culture --- mycelium --- antioxidant activity --- gamma irradiation --- Fomes fomentarius --- mushroom --- DPPH --- flavonoids --- polyphenols --- urinary infection --- in vitro --- Escherichia coli --- antimicrobial --- yellow onion skins --- extraction --- multifunctional ingredients --- Ficus carica L. --- ultrasonic enzyme co-assisted --- aqueous two-phase extraction --- UPLC-QTOF-MS/MS --- identification --- lactic acid fermentation --- betalain --- carotenoids --- red pepper --- beetroot --- carrot --- drying --- heat treatment --- seaweeds --- bioactive compounds --- food safety --- consumer health --- Cannabis sativa L. --- cannabinoids --- hemp oil --- UHPLC–PDA --- validation --- Cnidoscolus aconitifolius --- inflammation --- croton oil --- HL-60 --- phenols --- differentiation --- apoptosis --- transcriptome --- natural products --- bacteria --- downstream processing --- antibiotics --- isolation --- secondary metabolites --- pharmacognosy --- bioprospecting --- U. lactuca --- non-toxic solvents --- phenolics --- uropathogenic --- herbal medicines --- plant extract --- bioactive molecules --- n/a --- UHPLC-PDA